Cite
HARVARD Citation
Liu, X. et al. (2022). Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.. Journal of infection. 84 (6), pp. 795-813. [Online].